Alzheimer's Disease Diagnostics and Therapeutics Market Share

Statistics for the 2023 & 2024 Alzheimer's Disease Diagnostics and Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Alzheimer's Disease Diagnostics and Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Alzheimer's Disease Diagnostics and Therapeutics Industry

The Alzheimer's disease diagnostics and therapeutics market is moderately competitive and consists of several significant players; some of the companies are F. Hoffmann-La Roche, Bristol-Myers Squibb, AstraZeneca PLC, Corium Inc., Eisai Co. Ltd, Biogen Inc., Johnson & Johnson, Eli Lilly and Company, Lupin Limited, AbbVie Inc., Siemens Healthineers, Zydus Cadila, Merz Pharma, Teva Pharmaceutical Industries Ltd., and Adamas Pharmaceuticals Inc.

Alzheimer's Disease Diagnostics & Therapeutics Market Leaders

  1. F. Hoffmann-La Roche

  2. Bristol-Myers Squibb

  3. AstraZeneca PLC

  4. Johnson & Johnson

  5. Eli Lilly and Company

*Disclaimer: Major Players sorted in no particular order

Alzheimer's Disease Diagnostics and Therapeutics Market Concentration

Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)